Table 3.
Study | Marker | Cut-off | Survival analysis | HR | 95% CI | p value | Variables for multivariate analysis |
---|---|---|---|---|---|---|---|
Aggerholm-Pedersen et al. [30] | GPS | — | DSSa | 3.367 | 1.993-5.688 | <0.001 | Age, tumor size, histology, margin, soft tissue extension, comorbidity |
OSa | 3.387 | 2.062-5.564 | <0.001 | ||||
Liu et al. [31] | GPS | — | OS | 2.25 | 1.222-4.145 | 0.009 | Enneking stage, metastasis, tumor site, CRP, NLR, PLR, LMR |
Morhij et al. [32] | mGPS | — | CSS | 2.03 | 1.31-3.16 | 0.002 | Tumor size, grade, CRP, ALB, WCC |
RFS | 1.92 | 1.31-2.83 | 0.001 | Tumor size, grade, CRP, ALB | |||
Li et al. (1) [34] | GPS | — | OS | 1.95 | 1.33-2.87 | 0.001 | Univariate analysis |
CAR | 0.210 | OS | 2.62 | 1.70-4.03 | <0.001 | Metastasis, tumor site | |
Li et al. (2) [33] | GPS | — | OS | 2.27 | 1.28-4.02 | 0.006 | Univariate analysis |
CAR | 0.225 | OS | 2.28 | 1.23-4.26 | 0.009 | Enneking stage, tumor site | |
Maretty-Kongstad et al. [35] | GPS | — | DSSa | 1.731 | 1.070-2.801 | 0.026 | Age, tumor size, grade, histology, tumor depth, comorbidity |
Liang et al. [36] | Hs-mGPS | — | OSa | 3.162 | 2.000-4.998 | <0.001 | Univariate analysis |
DFSa | 2.232 | 1.542-3.231 | <0.001 | ||||
CAR | 0.1035 | OS | 2.47 | 1.47-4.14 | 0.001 | Grade | |
DFS | 1.88 | 1.22-2.91 | 0.004 | Age, grade | |||
Tsuda et al. [37] | Hs-mGPS | — | EFS | 1.74 | 1.01-2.99 | 0.046 | Age, sex, UICC stage, margin, ECOG PS |
Jiang et al. [38] | GPS | — | OS | 0.941 | 0.117-7.585 | 0.954 | mGPS, age, pathological grade, primary tumor depth |
PFS | 0.312 | 0.047-2.664 | 0.353 | ||||
mGPS | OS | 1.660 | 0.22-12.534 | 0.623 | GPS, age, pathological grade, primary tumor depth | ||
PFS | 9.932 | 1.357-72.716 | 0.024 | ||||
Sasaki et al. [39] | GPS | — | OS | 2.098 | 1.229-3.388 | 0.002 | Univariate analysis |
Aggerholm-Pedersen et al. [40] | GPS | — | DSSa | 3.195 | 1.253-8.147 | 0.015 | Age, comorbidity, histology, site of metastasis |
Xu et al. [41] | CAR | 1.5 | OS | 1.930 | 1.040-3.579 | 0.037 | Age, Frankel score, resection mode, D-dimer, PLR |
DFS | 1.687 | 0.916-3.106 | 0.093 | Age, Frankel score, metastasis, resection mode, D-dimer, PLR |
GPS: Glasgow prognostic score; mGPS: modified GPS; Hs-mGPS: high sensitive modified GPS; CAR: C-reactive protein to albumin ratio; OS: overall survival; DSS: disease-specific survival; DFS: disease-free survival; RFS: recurrence-free survival; EFS: event-free survival; PFS: progression-free survival; HR: hazard ratio; CI: confidence interval; CRP: C-reactive protein; NLR: neutrophil to lymphocyte ratio; PLR: platelet to lymphocyte ratio; LMR: lymphocyte to monocyte ratio; ALB: albumin; WCC: white cell counts; UICC: Union for International Cancer Control; ECOG PS: Eastern Cooperative Oncology Group performance status.aThese studies reported HRs for GPS 1 and GPS 2 separately. We combined these 2 groups and calculated a combined HR for the overall elevated GPS.